These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


527 related items for PubMed ID: 7371593

  • 1. Characterization of a unique population of unfilled estrogen-binding sites associated with the nuclear fraction of immature rat uteri.
    Carlson RA, Gorski J.
    Endocrinology; 1980 Jun; 106(6):1776-85. PubMed ID: 7371593
    [Abstract] [Full Text] [Related]

  • 2. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH, Markaverich B, Upchurch S, Eriksson H, Hardin JW.
    Adv Exp Med Biol; 1979 Jun; 117():17-46. PubMed ID: 474276
    [Abstract] [Full Text] [Related]

  • 3. Analysis of binding of [3H]Estradiol to the cytosol fraction of rat pancreas: comparison with sites in the cytosol of uterus.
    Boctor AM, Band P, Grossman A.
    Endocrinology; 1983 Aug; 113(2):453-62. PubMed ID: 6872936
    [Abstract] [Full Text] [Related]

  • 4. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS, Baudendistel LJ.
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [Abstract] [Full Text] [Related]

  • 5. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y, Maeda Y, Noma K, Sato B, Matsumoto K, Yamamura Y.
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Estrogen receptor in human endometrium--energy requirement, stability and subunit structure-- (author's transl)].
    Ozaki M, Kurachi K.
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug 20; 52(8):774-83. PubMed ID: 1035170
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B.
    Endocrinology; 1981 Apr 20; 108(4):1487-96. PubMed ID: 7472278
    [Abstract] [Full Text] [Related]

  • 13. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM, Roberts RR, Alejandro M, Clark JH.
    Endocrinology; 1984 Mar 20; 114(3):814-20. PubMed ID: 6697964
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of rat alpha-fetoprotein administration on estradiol free fraction, the onset of puberty, and neural and uterine nuclear estrogen receptors.
    Greenstein BD.
    Endocrinology; 1992 Jun 20; 130(6):3184-90. PubMed ID: 1375894
    [Abstract] [Full Text] [Related]

  • 17. Tissue and species specificity of unmasked nuclear acceptor sites for the estrogen receptor of Squalus testes.
    Ruh MF, Singh RK, Mak P, Callard GV.
    Endocrinology; 1986 Feb 20; 118(2):811-8. PubMed ID: 3943492
    [Abstract] [Full Text] [Related]

  • 18. Identification of estrogen receptors in granulosa cells of immature rats.
    Tonetta SA, Ireland JJ.
    Steroids; 1983 Oct 20; 42(4):427-40. PubMed ID: 6679947
    [Abstract] [Full Text] [Related]

  • 19. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites.
    Metzger DA, Curtis S, Korach KS.
    Endocrinology; 1991 Apr 20; 128(4):1785-91. PubMed ID: 2004602
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B, Happe HK.
    Endocrinology; 1986 Aug 20; 119(2):904-15. PubMed ID: 3732150
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.